Caiata-Zufferey, Maria - In: Social Science & Medicine 132 (2015) C, pp. 141-148
For the last 20 years, genetic tests have allowed unaffected women to determine whether they are predisposed to developing breast/ovarian cancer due to BRCA1/2 gene mutations. In the event of adverse results, women receive a specific label associated with a set of medical recommendations: the...